Bibliometric analysis of diabetes mellitus research output from Middle Eastern Arab countries during the period (1996–2012)

Scientometrics

Volumn 101, Issue 1, 2014, Pages 819-832

  Sweileh, Waleed M ^a   Zyoud, Sa’ed H ^a   Al Jabi, Samah W ^a   Sawalha, Ansam F ^a  

^a AN NAJAH NATIONAL UNIVERSITY   (Palestine)

Author keywords

Bibliometric; Diabetes mellitus; Impact factor; Middle Eastern Arab; Scopus

Indexed keywords

EID: 84939888379     PISSN: 01389130     EISSN: 15882861     Source Type: Journal    
DOI: 10.1007/s11192-014-1361-0     Document Type: Article

References (42)

1. Abdi, R., Fiorina, P., Adra, C. N., Atkinson, M., & Sayegh, M. H. (2008). Immunomodulation by mesenchymal stem cells: A potential therapeutic strategy for type 1 diabetes. Diabetes,57(7), 1759–1767.
2. Abramo, G., D’Angelo, C. A., & Di Costa, F. (2009). Research collaboration and productivity: Is there correlation? Higher Education,57(2), 155–171.
3. Ahmed, I., Adeghate, E., Sharma, A. K., Pallot, D. J., & Singh, J. (1998). Effects of Momordica charantia fruit juice on islet morphology in the pancreas of the streptozotocin-diabetic rat. Diabetes Research and Clinical Practice,40(3), 145–151.
4. Ahmed, I., Lakhani, M. S., Gillett, M., John, A., & Raza, H. (2001). Hypotriglyceridemic and hypocholesterolemic effects of anti-diabetic Momordica charantia (karela) fruit extract in streptozotocin-induced diabetic rats. Diabetes Research and Clinical Practice,51(3), 155–161.
5. Alberti, K. G. M. M., & Zimmet, P. Z. (1998). Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabetic Medicine,15(7), 539–553.
6. Al-Lawati, J. A., Mohammed, A. J., Al-Hinai, H. Q., & Jousilahti, P. (2003). Prevalence of the metabolic syndrome among Omani adults. Diabetes Care,26(6), 1781–1785.
7. Aronson, B. (2002). WHO’s Health InterNetwork Access to Research Initiative (HINARI). Health Information & Libraries Journal,19(3), 164–165.
8. Bissar-Tadmouri, N., & Tadmouri, G. O. (2009). Bibliometric analyses of biomedical research outputs in Lebanon and the United Arab Emirates (1988–2007). Saudi Medical Journal,30(1), 130–139.
9. Bramness, J. G., Henriksen, B., Person, O., & Mann, K. (2014). A Bibliometric Analysis of European versus USA Research in the Field of Addiction. Research on Alcohol, Narcotics, Prescription Drug Abuse, Tobacco and Steroids 2001-2011. European Addiction Research,20(1), 16–22.
10. De Battisti, F., & Salini, S. (2013). Robust analysis of bibliometric data. Statistical Methods and Applications,22(2), 269–283.
11. de Granda-Orive, J. I., Alonso-Arroyo, A., & Roig-Vazquez, F. (2011). Which data base should we use for our literature analysis? Web of Science versus SCOPUS. Archivos de Bronconeumologia,47(4), 213.
12. Engelgau, M. M., Thompson, T. J., Herman, W. H., Boyle, J. P., Aubert, R. E., Kenny, S. J., et al. (1997). Comparison of fasting and 2-hour Glucose and HbA(1c) levels for diagnosing diabetes: Diagnostic criteria and performance revisited. Diabetes Care,20(5), 785–791.
13. Falagas, M. E., Pitsouni, E. I., Malietzis, G. A., & Pappas, G. (2008). Comparison of PubMed, Scopus, web of science, and Google scholar: strengths and weaknesses. The FASEB Journal,22(2), 338–342.
14. Figg, W. D., Dunn, L., Liewehr, D. J., Steinberg, S. M., Thurman, P. W., Barrett, J. C., et al. (2006). Scientific collaboration results in higher citation rates of published articles. Pharmacotherapy,26(6), 759–767.
15. Gavin, J. R., Alberti, K. G. M. M., Davidson, M. B., DeFronzo, R. A., Drash, A., Gabbe, S. G., et al. (2003). Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care,26(SUPPL. 1), S5–S20.
16. Genuth, S., Alberti, K. G. M. M., Bennett, P., Buse, J., DeFronzo, R., Kahn, R., et al. (2003). Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care,26(11), 3160–3167.
17. Harris, M. I., Flegal, K. M., Cowie, C. C., Eberhardt, M. S., Goldstein, D. E., Little, R. R., et al. (1998). Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults: The Third National Health and Nutrition Examination Survey, 1988–1994. Diabetes Care,21(4), 518–524.
18. Hofman, K., Ryce, A., Prudhomme, W., & Kotzin, S. (2006). Reporting of non-communicable disease research in low- and middle-income countries: a pilot bibliometric analysis. J Med Libr Assoc,94(4), 415–420.
19. Huber, J. T., & Gullion, J. S. (2003). Complementary and alternative medicine as represented in the HIV/AIDS body of knowledge: a bibliometric analysis. Medical Reference Services Quarterly,22(3), 23–32.
20. Isomaa, B., Almgren, P., Tuomi, T., Forsén, B., Lahti, K., Nissén, M., et al. (2001). Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care,24(4), 683–689.
21. Janssen, B., Hohenadel, D., Brinkkoetter, P., Peters, V., Rind, N., Fischer, C., et al. (2005). Carnosine as a protective factor in diabetic nephropathy: association with a leucine repeat of the carnosinase gene CNDP1. Diabetes,54(8), 2320–2327.
22. Kahn, R. (1997). Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care,20(7), 1183–1197.
23. Khader, Y. S., Dauod, A. S., El-Qaderi, S. S., Alkafajei, A., & Batayha, W. Q. (2006). Periodontal status of diabetics compared with nondiabetics: A meta-analysis. Journal of Diabetes and Its Complications,20(1), 59–68.
24. King, H., Aubert, R. E., & Herman, W. H. (1998). Global burden of diabetes, 1995–2025: Prevalence, numerical estimates, and projections. Diabetes Care,21(9), 1414–1431.
25. Kulkarni, A. V., Aziz, B., Shams, I., & Busse, J. W. (2009). Comparisons of citations in Web of Science, Scopus, and Google Scholar for articles published in general medical journals. JAMA,302(10), 1092–1096.
26. Lee, S., & Bozeman, B. (2005). The impact of research collaboration on scientific productivity. Social Studies of Science,35(5), 673–702.
27. Matsuda, M., & DeFronzo, R. A. (1999). Insulin sensitivity indices obtained from oral glucose tolerance testing: Comparison with the euglycemic insulin clamp. Diabetes Care,22(9), 1462–1470.
28. Miro, O., Montori, E., Ramos, X., Galicia, M., & Nogue, S. (2009). Trends in research activity in toxicology and by toxicologists in seven European countries. Toxicology Letters,189(1), 1–4.
29. Pan, X. R., Li, G. W., Hu, Y. H., Wang, J. X., Yang, W. Y., An, Z. X., et al. (1997). Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: The Da Qing IGT and diabetes study. Diabetes Care,20(4), 537–544.
30. Rashidi, A., Rahimi, B., & Delirrad, M. (2013). Bibliometric analysis of parasitological research in iran and Turkey: A comparative study. Iranian Journal of Parasitology,8(2), 313–322.
31. Salti, I., Benard, E., Detournay, B., Bianchi-Biscay, M., Le Brigand, C., Voinet, C., et al. (2004). A population-based study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries: results of the epidemiology of diabetes and Ramadan 1422/2001 (EPIDIAR) study. Diabetes Care,27(10), 2306–2311.
32. ®Scopus. 2012 [cited 2012 19 October]; Available from: http://www.info.sciverse.com/UserFiles/2508.SciVerse.Scopus_Facts_Figures%28LR%29.pdf
33. Shaw, J. E., Sicree, R. A., & Zimmet, P. Z. (2010). Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Research and Clinical Practice,87(1), 4–14.
34. Simmons, R. K., Alberti, K. G., Gale, E. A., Colagiuri, S., Tuomilehto, J., Qiao, Q., et al. (2010). The metabolic syndrome: Useful concept or clinical tool? Report of a WHO Expert Consultation. Diabetologia,53(4), 600–605.
35. Tadmouri, G. O., & Bissar-Tadmouri, N. (2004). A major pitfall in the search strategy on PubMed. Saudi Medical Journal,25(1), 7–10.
36. Van Essen, C., Cartledge, P., Kyamanywa, P., & Manirakiza, A. (2012). Is HINARI appropriate for medical students in the developing world? Tropical Medicine & International Health,17(4), 406–408.
37. Wallin, J. A. (2005). Bibliometric methods: pitfalls and possibilities. Basic & Clinical Pharmacology & Toxicology,97(5), 261–275.
38. Whiting, D. R., Guariguata, L., Weil, C., & Shaw, J. (2011). IDF diabetes atlas: Global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Research and Clinical Practice,94(3), 311–321.
39. Wild, S., Roglic, G., Green, A., Sicree, R., & King, H. (2004). Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care,27(5), 1047–1053.
40. Ziyadeh, F. N., & Wolf, G. (2008). Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy. Current Diabetes Review,4(1), 39–45.
41. Zyoud, S., Al-Jabi, S., Sweileh, W., and Awang, R. (2013). A bibliometric analysis of research productivity of Malaysian publications in leading toxicology journals during a 10-year period (2003–2012). Human & Experimental Toxicology, Article in Press.
42. Zyoud, S. H., Al-Jabi, S. W., Sweileh, W. M., & Awang, R. (2014). A bibliometric analysis of toxicology research productivity in Middle Eastern Arab countries during a 10-year period (2003–2012). Health Research Policy and Systems,12(1), 4.